日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

一项随机、安慰剂对照的 2 期研究,比较紫杉醇联合瑞帕辛与紫杉醇单药治疗转移性三阴性乳腺癌的一线疗效 (fRida)

Lori J Goldstein, Mauro Mansutti, Christelle Levy, Jenny C Chang, Stephanie Henry, Isaura Fernandez-Perez, Jana Prausovà, Elzbieta Staroslawska, Giuseppe Viale, Beth Butler, Susan McCanna, Pier Adelchi Ruffini, Max S Wicha, Anne F Schott; fRida Trial Investigators

A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

CXCR1/2 抑制剂瑞帕林在可手术 HER-2 阴性乳腺癌中的机会窗口试验

Lori J Goldstein, Raymond P Perez, Denise Yardley, Linda K Han, James M Reuben, Hui Gao, Susan McCanna, Beth Butler, Pier Adelchi Ruffini, Yi Liu, Roberto R Rosato, Jenny C Chang

High rates of severe hypoglycemia among African American patients with diabetes: the surveillance, prevention, and Management of Diabetes Mellitus (SUPREME-DM) network

非裔美国糖尿病患者严重低血糖发生率高:糖尿病监测、预防和管理(SUPREME-DM)网络

Karter, Andrew J; Lipska, Kasia J; O'Connor, Patrick J; Liu, Jennifer Y; Moffet, Howard H; Schroeder, Emily B; Lawrence, Jean M; Nichols, Gregory A; Newton, Katherine M; Pathak, Ram D; Desai, Jay; Waitzfelder, Beth; Butler, Melissa G; Thomas, Abraham; Steiner, John F

Diabetes care and outcomes for American Indians and Alaska natives in commercial integrated delivery systems: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) Study

在商业化综合医疗服务体系中,美国印第安人和阿拉斯加原住民的糖尿病护理和治疗结果:一项糖尿病监测、预防和管理(SUPREME-DM)研究

Schmittdiel, Julie A; Steiner, John F; Adams, Alyce S; Dyer, Wendy; Beals, Janette; Henderson, William G; Desai, Jay; Morales, Leo S; Nichols, Gregory A; Lawrence, Jean M; Waitzfelder, Beth; Butler, Melissa G; Pathak, Ram D; Hamman, Richard F; Manson, Spero M